Coillard C, Circo A B, Rivard C H
Sainte Justine Hospital, Montréal, QC, Canada -
Eur J Phys Rehabil Med. 2014 Oct;50(5):479-87.
The purpose of this randomized controlled trial was to evaluate the efficacy of the Dynamic SpineCor brace for early idiopathic scoliosis (15°-30°) compared to the natural evolution of the disease. 68 patients participated in this study (32 treated and 36 controls) with at least 5 years follow-up.
The inclusion criteria were: 1) high risk of evolution: family history and/or proven progressive; 2) no significant pathological malformation of the spine; 3) initial Cobb angle between 15° and 30°; 4) risser 0, 1 or 2. Assessment of brace efficacy included the percentage of patients who have 5º or less curve progression and the percentage of patients who have 6º or more progression at skeletal maturity.
At five-year follow-up a correction was achieved in 50% of treated patient and only in 9.5% of controls, stabilization in 42.3% treated and 47.7% in controls and progression in 26.9% for the treated group and 42.8% for controls. For the control patients we considered as a failure if the Cobb angle worsened by more then 5° from the original angle and the patient then received treatment.
The results 5 years after the treatment suggested that the SpineCor brace reduced the probability of the progression of early idiopathic scoliosis comparing with its natural history. Moreover, the positive outcome appears to be maintained in the long term.
本随机对照试验的目的是评估动态脊柱矫正器(Dynamic SpineCor brace)用于治疗早期特发性脊柱侧弯(15°-30°)相较于疾病自然发展进程的疗效。68名患者参与了本研究(32名接受治疗,36名作为对照),随访时间至少5年。
纳入标准为:1)进展风险高:有家族病史和/或已证实病情进展;2)脊柱无明显病理性畸形;3)初始Cobb角在15°至30°之间;4)Risser分级为0、1或2级。对矫正器疗效的评估包括脊柱侧弯进展5°及以下的患者百分比,以及骨骼成熟时进展6°及以上的患者百分比。
在五年随访时,50%接受治疗的患者实现了侧弯矫正,而对照组仅有9.5%;42.3%接受治疗的患者侧弯稳定,对照组为47.7%;治疗组侧弯进展的患者为26.9%,对照组为42.8%。对于对照患者,如果Cobb角相较于初始角度恶化超过5°且随后接受治疗,我们将其视为治疗失败。
治疗五年后的结果表明,与自然病程相比,SpineCor矫正器降低了早期特发性脊柱侧弯进展的可能性。此外,积极的治疗效果似乎能长期维持。